As demonstrated in Figs. 4, 5, and 6, the triplet Ad-p53 + CD122/132 + anti-PD-1 therapy was the only treatment that resulted in complete tumor remissions and long-term survival. This evidence concerns the gene IL2RB and neoplasm.